Luote Wei (罗特威)罗特威

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

收获病毒液并加入蔗糖是一种在国家药监局注册认定的药品。该药品含有经培养-c551017b等成分。

该药品关联的活性成分包括:经培养Jingpei Yang。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:兰州生物制品研究所有限责任公司Chinese legal name: 兰州生物制品研究所有限责任公司。

您可以探索含有相同成分的其他药品:经培养-c551017b成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 罗特威) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 经培养Jingpei Yang.

Manufacturers recorded for this product: 兰州生物制品研究所有限责任公司Chinese legal name: 兰州生物制品研究所有限责任公司.

Explore other medicines containing the same ingredient: 经培养 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 罗特威Recorded Chinese name: 罗特威
  • 规格Specification: 3ml3 mL

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 兰州生物制品研究所有限责任公司Chinese legal name: 兰州生物制品研究所有限责任公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字S20010002

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字S20010002

Manufacturer

Chinese legal name: 兰州生物制品研究所有限责任公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字S20010002

生产企业

兰州生物制品研究所有限责任公司(国产)

适应症

本疫苗为主要用于2个月至3岁婴幼儿。本品免疫接种后,可刺激机体产生对A群轮状病毒的免疫力,用于预防婴幼儿A群轮状病毒引起的腹泻。

用法用量

开启瓶盖,用吸管吸取本疫苗,直接喂于婴幼儿。用量为每人一次口服3ml。每年应服一次。

不良反应

口服后一般无不良反应;偶有低热、呕吐、腹泻、皮疹等轻微反应,多为一次性,一般无需特殊处理,必要时给予对症治疗。

禁忌

1. 身体不适,发热,腋温37.5℃以上者。|2. 急性传染病或其他严重疾病者。|3. 免疫缺陷和接受免疫抑制治疗者。

注意事项

1. 包装容器有裂纹、标签不清、超过有效期或液体浑浊者均不可使用。|2. 包装容器开启后,疫苗应在1小时内用完。|3. 使用本疫苗前、后须与使用其他活疫苗或免疫球蛋白间隔2周以上。|4. 请勿用热开水送服,以免影响疫苗免疫效果。|5. 本疫苗为口服疫苗,严禁注射。|6. 本品为活疫苗,不推荐在该疾病流行季节使用。|7. 应备有肾上腺素等药物,以备偶有发生的严重过敏反应时急救用。服苗者在服苗后应在现场观察至少30分钟。

贮藏

于2-8℃避光保存和运输。

规格

3ml

证据Evidence

  • 批准文号: 国药准字S20010002
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.